Identify potentially COVID-19 contagious patients with or without symptoms in 15 minutes to reduce virus spread with PANBIO COVID-19 Ag rapid test device. Patient-friendly nasal self-collected swab option minimises health worker exposure. Clinical performance data calculated vs nasopharyngeal swab specimens using an FDA EUA RT-PCR reference and has a sensitivity of 91.1% (95% CI: 84.2-95.6%) and specificity of 99.7% (95% CI: 98.6-100.0%). TESTING USE CASES • Screening asymptomatic individuals • Individuals presenting with symptoms in the last 7 days • Individuals suspected of exposure to COVID-19 The Panbio COVID-19 Ag Rapid Test Device is accessible, affordable, easy to deploy, and provides quick, reliable results to help slow disease spread. Panbio COVID-19 Ag rapid test devices have demonstrated strong performance in suspected and symptomatic patients. Studies including 508 individuals investigated the performance of the Panbio COVID-19 Ag Rapid Test Device using a nasal swab compared to nasal PCR from a population of individuals who were suspected of exposure to COVID-19 or presented with symptoms in the last 7 days. SPECIFICATIONS • Test Time: 15 Minutes • STORAGE: 2 ' 30 Degrees Celsius • Sample Type: Nasal Swab Contents: 25 Test Devices, 1 Buffer (9 mL/bottle), 25 Extraction Tubes, 25 Extraction Tube Caps, 1 Positive Control Swab, 1 Negative Control Swab, 25 Sterilized Nasal Swabs for Sample Collection, 1 Tube Rack, 1 Quick Reference Guide, 1 Instructions for Use To be eligible to purchase this product, please complete the Qualification for Supply COVID-19 Tests Form. This can be found in the additional information tab on this page.